Skip to main content

MoneyWorks4Me

A decent increase of about 27.72% in the sales to Rs. 3950.47 millions was observed for the quarter ended September 2026. The sales figure stood at Rs. 3093.15 millions during the year-ago period.Good  Net Profit growth of 39.11% reported above the corresponding previous quarter figure of Rs. 234.62 millions to Rs. 326.37 millioins.OP of the company witnessed a marginal growth to 603.64 millions from 439.68 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 3950.47 3093.15 27.72 7873.22 6417.58 22.68 13487.36 13117.84 2.82
Other Income 257.97 270.77 -4.73 519.01 556.32 -6.71 1129.65 1241.92 -9.04
PBIDT 603.64 439.68 37.29 1349.71 1166.31 15.72 2104.25 2626.91 -19.90
Interest 30.03 20.77 44.58 54.79 49.88 9.84 100.38 153.09 -34.43
PBDT 573.61 418.91 36.93 1294.92 1116.43 15.99 1938.68 2473.82 -21.63
Depreciation 135.13 106.90 26.41 263.08 209.36 25.66 455.03 395.45 15.07
PBT 438.48 312.01 40.53 1031.84 907.07 13.76 1483.65 2078.37 -28.61
TAX 112.11 77.39 44.86 257.08 223.78 14.88 367.25 468.39 -21.59
Deferred Tax -5.66 -5.74 -1.39 -14.19 -21.58 -34.24 -3.69 -7.14 -48.32
PAT 326.37 234.62 39.11 774.76 683.29 13.39 1116.40 1609.98 -30.66
Equity 306.21 306.21 0.00 306.21 306.21 0.00 306.21 306.21 0.00
PBIDTM(%) 15.28 14.21 7.50 17.14 18.17 -5.67 15.60 20.03 -22.09
Peers
Company Name CMP
Sun Pharma. Inds. 1793.75
Dr. Reddys Labs. 1372.50
Cipla 1397.80
Lupin 2049.50
Zydus Lifesciences 1255.15
View more..